Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MYD88 antibody

MYD88 Reactivity: Human WB, IHC, IF, FACS Host: Mouse Monoclonal 2B2 unconjugated
Catalog No. ABIN2726635
  • Target See all MYD88 Antibodies
    MYD88 (Myeloid Differentiation Primary Response Gene (88) (MYD88))
    Reactivity
    • 94
    • 60
    • 49
    • 16
    • 7
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 86
    • 13
    • 2
    Mouse
    Clonality
    • 79
    • 22
    Monoclonal
    Conjugate
    • 61
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This MYD88 antibody is un-conjugated
    Application
    • 82
    • 30
    • 23
    • 14
    • 14
    • 14
    • 13
    • 13
    • 11
    • 9
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)
    Characteristics
    Homo sapiens myeloid differentiation primary response gene (88) (MYD88), transcript variant 2
    Purification
    Purified from mouse ascites fluids by affinity chromatography
    Immunogen
    Full length human recombinant protein of human MYD88 (NP_002459) produced in HEK293T cell.
    Clone
    2B2
    Isotype
    IgG2a
    Top Product
    Discover our top product MYD88 Primary Antibody
  • Application Notes
    WB 1:2000, IHC 1:150, IF 1:100, FLOW 1:100
    Comment

    The concentration of the product may vary between diferrent lots.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5-1.0 mg/mL
    Buffer
    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
  • Mendez, Banerjee: "Proximal Ligation Assay (PLA) on Lung Tissue and Cultured Macrophages to Demonstrate Protein-protein Interaction." in: Bio-protocol, Vol. 7, Issue 21, (2017) (PubMed).

    Caner, Sen Turk, Baris, Cetin, Tepeli, Hacioglu, Sari, Zencir, Dogu, Bagci, Keskin: "MYD88 Expression and L265P Mutation in Mature B-Cell Non-Hodgkin Lymphomas." in: Genetic testing and molecular biomarkers, Vol. 19, Issue 7, pp. 372-8, (2015) (PubMed).

    Choi, Kim, Lee, Kim: "MYD88 expression and L265P mutation in diffuse large B-cell lymphoma." in: Human pathology, (2013) (PubMed).

  • Target
    MYD88 (Myeloid Differentiation Primary Response Gene (88) (MYD88))
    Alternative Name
    MYD88 (MYD88 Products)
    Background
    This gene encodes a cytosolic adapter protein that plays a central role in the innate and adaptive immune response. This protein functions as an essential signal transducer in the interleukin-1 and Toll-like receptor signaling pathways. These pathways regulate that activation of numerous proinflammatory genes. The encoded protein consists of an N-terminal death domain and a C-terminal Toll-interleukin1 receptor domain. Patients with defects in this gene have an increased susceptibility to pyogenic bacterial infections. Alternate splicing results in multiple transcript variants.
    Molecular Weight
    33.1 kDa
    Gene ID
    4615
    NCBI Accession
    NM_002468
    HGNC
    4615
    Pathways
    NF-kappaB Signaling, TLR Signaling, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Toll-Like Receptors Cascades
Support